# Rezvoglar KwikPen

NDC: 0002-8980
Generic name: Insulin glargine-aglr
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20211217

FDA application: BLA761215

## Active ingredients

- INSULIN GLARGINE: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-8980"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-8980
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6af8706-2058-4fe1-99c8-43684c20bfa2